About
Element Biosciences is a life sciences company focused on developing innovative technologies for genomic and multiomic analysis. Their mission is to democratize sequencing by providing accessible, high-performance solutions for research, translational science, and diagnostic applications. They aim to empower scientists and clinicians with faster, more comprehensive, and cost-effective tools for understanding the genome.
Key facts
At-a-glance profile data
- Website
- elementbiosciences.com
- Headquarters
- San Diego, California, USA
- Founded
- 2017
- Total funding
- $175M (Series E)
- Business model
- B2B
Funding rounds
Tech stack
Detected on elementbiosciences.com, last scanned 21 Sept 2026. Run your own scan
- Frontend
- Bootstrap
- Analytics
- Google Tag Manager
- Support
- HubSpot
- CMS / Builders
- Salesforce
- CDN
- Cloudflare
- Cookie consent
- Osano
“Illumina ($ILMN) has filed a lawsuit against Element Biosciences, alleging that Element is infringing on five of its patents related to flow cell and imaging technologies used in genetic sequencing. This legal battle might be a sign that Il…”
View on Reddit“Hi everyone, I’m exploring the use of Element Biosciences AVITI and considering buying it for our lab and wanted to gather some insights from those who have experience with it. Specifically, I have a few questions about data analysis and co…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has Element Biosciences raised?
Element Biosciences has raised a total of $175M in funding. The most recent round on record is Series E.